Legal Opinion

Apotex Inc. v. Acorda Therapeutics, Inc.

Court of Appeals for the Second Circuit

Decided May 16, 2016No. Docket No. 14-4353-cvPublishedCited by 135 opinions

1Opinion of the Court

DENNIS JACOBS, Circuit Judge:

The parties are rival manufacturers of tizanidine, a drug for treating spasticity. Plaintiffs Apotex Incorporated and Apotex Corporation (collectively “Apotex”) allege that defendant Acorda Therapeutics, Inc. (“Acorda”) (i) filed a sham citizen petition with the Food and Drug Administration (“FDA”) to hinder approval of Apotex’s competing formulation in violation of Section Two of the Sherman Act, and (ii) violated the Lanham Act’s proscription on false advertising. As relevant here, the competition between the manufacturers focused on the relative efficacy of…

2Cases cited33 opinions

  1. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  2. Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
  3. Papasan v. AllainSupreme Court of the United States · 1986
  4. Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
  5. Christiansburg Garment Co. v. Equal Employment Opportunity CommissionSupreme Court of the United States · 1978

28 more not listed; retrieve them via the Exa API.

3Cited by135 opinions

  1. Davila v. LangDistrict Court, S.D. Illinois · 2018
  2. Pasternack v. ShraderCourt of Appeals for the Second Circuit · 2017
  3. Fischer v. ForrestDistrict Court, S.D. Illinois · 2018
  4. Church & Dwight Co., Inc. v. SPD Swiss Precision Diagnostics, GmbHCourt of Appeals for the Second Circuit · 2016
  5. In Re Lipitor Antitrust LitigationCourt of Appeals for the Third Circuit · 2017

130 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API